Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 19;6(6):922-931.
doi: 10.1016/j.jaccao.2024.09.011. eCollection 2024 Dec.

Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy

Affiliations

Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy

Maarten J Beekman et al. JACC CardioOncol. .

Abstract

Background: Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, evidence on long-term cardiovascular disease risk after early surgical menopause is scarce.

Objectives: We sought to determine the long-term influence of the timing of RRSO on the development of coronary artery calcium (CAC), an established marker for cardiovascular disease risk.

Methods: We conducted a cross-sectional study (N = 733) nested in a nationwide cohort of women at high familial risk of ovarian cancer. In women aged 60-70 years (n = 328), we compared CAC scores between women with a premenopausal RRSO (age ≤45 years) and women with a postmenopausal RRSO (age ≥54 years), using multivariable Poisson analyses. Within the premenopausal RRSO group (n = 498), we also examined the effect of age at RRSO. In addition, we compared the premenopausal RRSO group with an external reference cohort (n = 5,226).

Results: Multivariable analyses showed that the prevalence rates of any CAC (CAC >0), at least moderate CAC (CAC >100), and severe CAC (CAC >400) were comparable between the premenopausal and postmenopausal RRSO groups (relative risk [RR]: 0.93; 95% CI: 0.75-1.15 for any CAC; RR: 0.71; 95% CI: 0.43-1.17 for at least moderate CAC; RR: 0.81; 95% CI: 0.30-2.13 for severe CAC). There was no difference in CAC between the premenopausal RRSO group and a similar aged reference cohort. Timing of premenopausal RRSO (early premenopausal RRSO [<41 years] vs late premenopausal RRSO [41-45 years]) did not affect the outcomes.

Conclusions: Our results do not show a long-term adverse effect of surgical menopause on the development of CAC.

Keywords: BRCA; CAC; RRSO; cardiovascular disease; ovarian cancer; surgical menopause.

PubMed Disclaimer

Conflict of interest statement

The Dutch Cancer Society (KWF) and the Maarten van der Weijden foundation funded this project, registered under grant 10164. The funding body had no role in the design of the study, collection, analysis or interpretation of data or in writing the paper. Dr van der Aalst has received an advanced research grant for ROBINSCA by the European Research Council. Dr Budde has received institutional support to the radiology department of the Erasmus Medical Center by Siemens and HeartFlow; payments to the Erasmus MC for lectures by Bayer and Siemens; and serves unpaid as board member of the European Society of Cardiovascular Radiology and the editorial boards of Radiology: Cardiothoracic Imaging, EHJ Digital Health, and Journal of Hybrid Imaging. Dr de Jong has received research support to the department of radiology of UMC Utrecht by Philips Healthcare. Dr Vliegenthart has received institutional research grants by Siemens Healthineers, Dutch Heart Foundation, Dutch Cancer Foundation, and Netherlands organization for Health Research and Development; speaker fees by Siemens Healthineers and Bayer Healthcare; participates in the strategic advisory board of the Institute for Cardiometabolism and Nutrition; and is president of the European Society of Cardiovascular Radiology. Dr Ausems has received institutional payments by AstraZeneca. Dr de Koning has received institutional grants for the 4-in-the-lung-run trial HORIZON 2020. Dr Maas has received speaker fees by Novartis, Organon and Omron. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Flowchart of Participation in the HARMOny Study The colors represent the 3 different statistical comparisons made: blue illustrates coronary artery calcium (CAC) scores of the HARMOny (Health After eaRly Menopause Due to Oophorectomy) premenopausal risk-reducing salpingo-oophorectomy (RRSO) group vs the postmenopausal RRSO group (aged 60-70 years at the study visit); grey shows CAC scores of the HARMOny early premenopausal RRSO group (age ≤41 years) vs the late premenopausal RRSO group (age 41-45 years); and pink compares CAC scores of the premenopausal RRSO group from HARMOny eligible for the ROBINSCA (Risk or Benefit in Screening for Cardiovascular Disease) cohort vs the ROBINSCA external reference cohort (aged 55-70 years at the study visit). This latter comparison is indicated by a dashed line.
Central Illustration
Central Illustration
Relative Risks of Increased CAC Scores Relative risks of increased coronary artery calcium (CAC) scores according to the timing of risk-reducing salpingo-oophorectomy (RRSO) and other risk factors are shown. After a median follow-up of 21.0 years, women who underwent premenopausal RRSO did not have an elevated risk of increased CAC scores, adjusted for age, hypertension ,and dyslipidemia, when compared with women who underwent postmenopausal RRSO or to the general population. Hypertension and dyslipidemia were independent risk factors for increased CAC scores. HARMOny = Health After eaRly Menopause Due to Oophorectomy.

References

    1. Henderson J.T., Webber E.M., Sawaya G.F. Screening for ovarian cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(6):595–606. - PubMed
    1. Daly M.B., Pal T., Berry M.P., et al. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(1):77–102. - PubMed
    1. Domchek S.M., Friebel T.M., Singer C.F., et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967–975. - PMC - PubMed
    1. Rebbeck T.R., Kauff N.D., Domchek S.M. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101(2):80–87. - PMC - PubMed
    1. Dam V., van der Schouw Y.T., Onland-Moret N.C., et al. Association of menopausal characteristics and risk of coronary heart disease: a pan-European case-cohort analysis. Int J Epidemiol. 2019;48(4):1275–1285. - PMC - PubMed

LinkOut - more resources